Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 549Carcinoma, Non-Small-Cell Lung 506Prostatic Neoplasms 335Colorectal Neoplasms 268Multiple Myeloma 267Neoplasms 259Leukemia, Myeloid, Acute 218Squamous Cell Carcinoma of Head and Neck 213Lung Neoplasms 206Neoplasm Metastasis 204Carcinoma, Hepatocellular 197Triple Negative Breast Neoplasms 172Melanoma 172Pancreatic Neoplasms 171Recurrence 153Ovarian Neoplasms 151Lymphoma 140Sarcoma 132Glioblastoma 132Brain Neoplasms 132Head and Neck Neoplasms 126Carcinoma, Renal Cell 126Leukemia, Lymphocytic, Chronic, B-Cell 125Stomach Neoplasms 123Lymphoma, Large B-Cell, Diffuse 123Rectal Neoplasms 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 104Uterine Cervical Neoplasms 101Urinary Bladder Neoplasms 101Myelodysplastic Syndromes 101

Interventions

apalutamide 1abiraterone 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostate Cancer Metastatic Disease × 1 year × Clear all
NCT06832774 2026-03-25

Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
192 enrolled
Genitourinary

Prostate Cancer Metastatic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡